These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21150841)

  • 1. Preventive thyroidectomy in patients with hereditary medullary thyroid carcinoma found heterozygote for mutant RET proto-oncogene.
    Konstantinou E; Sapsakos Mariolis T; Fotis T; Mitsos A; Restos S; Mamoura K; Soultati A; Elefsiniotis I; Kapellakis G
    Pediatr Endocrinol Rev; 2010 Dec; 8(2):108-13. PubMed ID: 21150841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. When should thyroidectomy be performed in familial medullary thyroid carcinoma gene carriers with non-cysteine RET mutations?
    Niccoli-Sire P; Murat A; Rohmer V; Gibelin H; Chabrier G; Conte-Devolx B; Visset J; Ronceray J; Jaeck D; Henry JF; Proye C; Carnaille B; Kraimps JL;
    Surgery; 2003 Dec; 134(6):1029-36; discussion 1036-7. PubMed ID: 14668737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prophylactic thyroidectomy in children who are carriers of a multiple endocrine neoplasia type 2 mutation: description of 20 cases and recommendations based on the literature].
    de Groot JW; Links TP; Rouwe CW; van der Wal JE; Hofstra RM; Plukker JT
    Ned Tijdschr Geneeskd; 2006 Feb; 150(6):311-8. PubMed ID: 16503023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When is prophylactic thyroidectomy indicated for patients with the RET codon 609 mutation?
    Calva D; O'Dorisio TM; Sue O'Dorisio M; Lal G; Sugg S; Weigel RJ; Howe JR
    Ann Surg Oncol; 2009 Aug; 16(8):2237-44. PubMed ID: 19472011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late-onset medullary carcinoma of the thyroid: need for genetic testing and prophylactic thyroidectomy in adult family members.
    Shaha AR; Cohen T; Ghossein R; Tuttle RM
    Laryngoscope; 2006 Sep; 116(9):1704-7. PubMed ID: 16955009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualization of lymph node dissection in RET (rearranged during transfection) carriers at risk for medullary thyroid cancer: value of pretherapeutic calcitonin levels.
    Machens A; Lorenz K; Dralle H
    Ann Surg; 2009 Aug; 250(2):305-10. PubMed ID: 19638924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations.
    Learoyd DL; Gosnell J; Elston MS; Saurine TJ; Richardson AL; Delbridge LW; Aglen JV; Robinson BG
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):636-41. PubMed ID: 16343097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2.
    Moore SW; Appfelstaedt J; Zaahl MG
    J Pediatr Surg; 2007 Feb; 42(2):326-32. PubMed ID: 17270543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic thyroidectomy in pediatric carriers of multiple endocrine neoplasia type 2A or familial medullary thyroid carcinoma: mutation in C620 is associated with Hirschsprung's disease.
    Bütter A; Gagné J; Al-Jazaeri A; Emran MA; Deal C; St-Vil D
    J Pediatr Surg; 2007 Jan; 42(1):203-6. PubMed ID: 17208566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation.
    Jaggard MK; MacRae C; Ifeacho S; Robinson S; Tolley NS
    J Laryngol Otol; 2009 Jul; 123(7):796-800. PubMed ID: 18771606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New mutations in the RET protooncogene-L881V - associated with medullary thyroid carcinoma and -R770Q - in a patient with mixed medullar/follicular thyroid tumour.
    Frank-Raue K; Döhring J; Scheumann G; Rondot S; Lorenz A; Schulze E; Dralle H; Raue F; Leidig-Bruckner G
    Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):550-3. PubMed ID: 20013610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mutations of ret-proto-oncogene in thyroid medullary carcinoma].
    Frank-Raue K; Höppner W; Buhr H; Herfarth C; Ziegler R; Raue F
    Dtsch Med Wochenschr; 1997 Feb; 122(6):143-9. PubMed ID: 9081799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sporadic hypercalcitoninemia: clinical and therapeutic consequences.
    Scheuba C; Kaserer K; Moritz A; Drosten R; Vierhapper H; Bieglmayer C; Haas OA; Niederle B
    Endocr Relat Cancer; 2009 Mar; 16(1):243-53. PubMed ID: 18987170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A.
    Skinner MA; Moley JA; Dilley WG; Owzar K; Debenedetti MK; Wells SA
    N Engl J Med; 2005 Sep; 353(11):1105-13. PubMed ID: 16162881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very early manifestation of hereditary medullary thyroid cancer in carriers of intracellular-domain RET mutations.
    Machens A; Dralle H
    J Pediatr Surg; 2007 Jun; 42(6):1153; author reply 1154. PubMed ID: 17560241
    [No Abstract]   [Full Text] [Related]  

  • 16. Medullary thyroid carcinoma.
    Pacini F; Castagna MG; Cipri C; Schlumberger M
    Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):475-85. PubMed ID: 20627492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype.
    Frank-Raue K; Buhr H; Dralle H; Klar E; Senninger N; Weber T; Rondot S; Höppner W; Raue F
    Eur J Endocrinol; 2006 Aug; 155(2):229-36. PubMed ID: 16868135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early malignant progression of hereditary medullary thyroid cancer.
    Machens A; Niccoli-Sire P; Hoegel J; Frank-Raue K; van Vroonhoven TJ; Roeher HD; Wahl RA; Lamesch P; Raue F; Conte-Devolx B; Dralle H;
    N Engl J Med; 2003 Oct; 349(16):1517-25. PubMed ID: 14561794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Is immediate prophylactic thyroidectomy indispensable in familiar medullary thyroid carcinoma?].
    Cañizo A; Fanjul M; Cerdá J; Menárguez J; Parente A; Laín A; Carrera N; Rodríguez-Arnao MD; Rodríguez-Sánchez A; Polo JR; Vázquez J
    Cir Pediatr; 2008 Apr; 21(2):100-3. PubMed ID: 18624279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical diagnosis and treatment of familial medullary thyroid carcinoma caused by a p.C618Y RET proto-oncogene mutation in a Chinese pedigree].
    Zhao JQ; Guo L; Qi XP; Chen ZG; Wang KJ; Lou JL; Yu XH; Cheng J; Jin HY; Li XL; Ying RB; Zhang XN
    Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(6):440-4. PubMed ID: 23660264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.